PhD conferral Ard Jan van Veelen
Supervisor: Prof. dr. V.C.G. Tjan - Heijnen
Co-supervisors: Dr. S. Croes, Dr. P.C. Souverein (Universiteit Utrecht), Dr. R.M.J.M. van Geel
Keywords: non-small cell lung cancer, osimertinib, treatment optimization
"Treatment optimization in patients with non-small cell lung cancer"
It is desirable for patients with non-small cell lung cancer (NSCLC) to be treated efficiently. This can apply for the effectiveness, the safety, or the costs of the treatment. In this thesis, research was performed in three different areas to evaluate potential treatment optimization in patients with NSCLC. Firstly, three analytical methods were developed and validated to quantify the concentration of several anti-cancer drugs in blood. In the second part, four observational studies were performed. This part consisted of two subsections: a) evaluation of the treatment outcomes with osimertinib, a specific anti-cancer drug, in the Dutch clinical practice, and b) two studies with two large, British, databases. In the last part of this thesis a clinical study is presented, in which the potential of increasing the osimertinib exposure was evaluated, without the need to increase the osimertinib intake. The results of this thesis can be used to guide the treatment of patients with NSCLC in the clinical practice, or serve as starting point for future research.
Language: Dutch
Click here for the live stream.
Administrative Office
Also read
-
23 Sep10:00
PhD Defence Nivine Hanach
"Postpartum Depression in the UAE: Insights, Challenges, and Pathways to Support"
-
23 Sep13:00
PhD Defence Francesco Schianchi
"From v-ATPase to protein palmitoylation: Novel targets against lipid-induced cardiomyopathy"
-
23 Sep16:00
PhD Defence Khava Im Elievna Ibragimova
"Real-world treatment patterns and outcomes of patients with HER2+ advanced breast cancer"